Symptoms
Common signs and symptoms of Medullary Thyroid Cancer include:
When to see a doctor
If you experience severe or worsening symptoms, seek immediate medical attention. Always consult with a healthcare professional for proper diagnosis and treatment.
Causes & Risk Factors
Several factors can contribute to Medullary Thyroid Cancer.
Medullary thyroid cancer develops when the C cells in the thyroid gland undergo genetic changes that cause them to grow and multiply uncontrollably.
Medullary thyroid cancer develops when the C cells in the thyroid gland undergo genetic changes that cause them to grow and multiply uncontrollably. These C cells, also called parafollicular cells, normally produce calcitonin to help regulate calcium levels in the body. When they become cancerous, they typically produce excessive amounts of this hormone, which serves as a marker for the disease.
The underlying causes fall into two main categories: sporadic and hereditary.
The underlying causes fall into two main categories: sporadic and hereditary. Sporadic cases, which make up about 75% of all medullary thyroid cancers, occur when genetic mutations develop spontaneously during a person's lifetime. Scientists haven't identified specific environmental triggers that cause these spontaneous mutations, though some research suggests that radiation exposure, particularly during childhood, may play a role.
Hereditary medullary thyroid cancer results from inherited mutations in the RET gene, which provides instructions for making proteins involved in cell signaling.
Hereditary medullary thyroid cancer results from inherited mutations in the RET gene, which provides instructions for making proteins involved in cell signaling. These inherited cases are often part of genetic syndromes called Multiple Endocrine Neoplasia (MEN) type 2A or 2B, or familial medullary thyroid cancer syndrome. People who inherit these genetic mutations have a very high likelihood of developing medullary thyroid cancer at some point in their lives, often at younger ages than those with sporadic cases.
Risk Factors
- Inherited RET gene mutations
- Family history of medullary thyroid cancer
- Multiple Endocrine Neoplasia (MEN) syndrome type 2A or 2B
- Previous radiation exposure to the head or neck
- Age between 40-60 years
- Female gender (slightly higher risk)
- History of other endocrine tumors
- Caucasian ethnicity
Diagnosis
How healthcare professionals diagnose Medullary Thyroid Cancer:
- 1
Diagnosing medullary thyroid cancer typically begins when someone notices a neck lump or when routine examination reveals a thyroid nodule.
Diagnosing medullary thyroid cancer typically begins when someone notices a neck lump or when routine examination reveals a thyroid nodule. The diagnostic process often starts with blood tests measuring calcitonin levels, since elevated calcitonin is a hallmark of this cancer. Normal calcitonin levels are very low, so even modest increases can signal the presence of medullary thyroid cancer. Doctors may also test carcinoembryonic antigen (CEA), another marker that's often elevated in this cancer.
- 2
Imaging studies help determine the size and spread of the cancer.
Imaging studies help determine the size and spread of the cancer. Ultrasound of the neck provides detailed images of the thyroid and nearby lymph nodes. A fine needle aspiration biopsy can confirm the diagnosis by examining cells under a microscope. Unlike other thyroid cancers, medullary thyroid cancer has distinctive cellular features that pathologists can readily identify. Additional imaging such as CT scans or MRI may be needed to assess whether the cancer has spread beyond the thyroid.
- 3
Genetic testing plays a crucial role in the diagnostic workup.
Genetic testing plays a crucial role in the diagnostic workup. All patients diagnosed with medullary thyroid cancer should undergo RET gene testing to determine if their cancer is hereditary. This information affects treatment decisions and determines whether family members need screening. If genetic testing reveals an inherited mutation, family members can be tested and potentially undergo preventive surgery before cancer develops. The genetic counseling process helps families understand the implications and make informed decisions about testing and treatment.
Complications
- The most common complications of medullary thyroid cancer relate to its tendency to spread to lymph nodes in the neck and, in advanced cases, to distant organs like the liver, lungs, and bones.
- When cancer spreads locally, it may grow large enough to compress the trachea or esophagus, causing breathing difficulties or trouble swallowing.
- Voice changes can occur if cancer affects the nerves that control the vocal cords.
- Systemic complications can develop when the cancer produces excessive hormones.
- High calcitonin levels rarely cause symptoms, but some patients with advanced disease experience chronic diarrhea.
- If medullary thyroid cancer is part of MEN syndrome, patients may develop other endocrine tumors, including pheochromocytomas (adrenal gland tumors that can cause dangerous blood pressure spikes) and parathyroid tumors that affect calcium regulation.
- Surgical complications, while uncommon with experienced surgeons, can include temporary or permanent voice changes and low calcium levels if parathyroid glands are inadvertently affected.
Prevention
- For the 75% of medullary thyroid cancers that occur sporadically, there are no proven prevention strategies since the underlying causes remain largely unknown.
- General cancer prevention measures like maintaining a healthy lifestyle, avoiding unnecessary radiation exposure, and eating a balanced diet may provide some benefit, though specific evidence for preventing medullary thyroid cancer is limited.
- The prevention picture changes dramatically for hereditary cases.
- People who test positive for RET gene mutations face a very high lifetime risk of developing medullary thyroid cancer, often approaching 100%.
- For these individuals, prophylactic thyroidectomy, or preventive removal of the thyroid gland, can effectively prevent cancer from developing.
- The timing of this surgery depends on the specific type of RET mutation and associated risk level.
- Genetic counseling and family screening represent the most powerful prevention tools available.
- When one family member is diagnosed with medullary thyroid cancer, genetic testing can identify other at-risk relatives before cancer develops.
- Children who test positive for high-risk mutations may undergo prophylactic surgery as early as age 5, while those with lower-risk mutations might wait until their teens or early adulthood.
- This proactive approach has dramatically improved outcomes for families affected by hereditary medullary thyroid cancer.
Surgery represents the primary and most effective treatment for medullary thyroid cancer.
Surgery represents the primary and most effective treatment for medullary thyroid cancer. Total thyroidectomy, which removes the entire thyroid gland, is the standard surgical approach because medullary thyroid cancer can develop in multiple areas of the thyroid. Surgeons also typically remove lymph nodes in the central neck compartment and sometimes additional lymph node groups if cancer has spread. The extent of lymph node removal depends on the size of the primary tumor and whether imaging shows suspicious lymph nodes.
Unlike other thyroid cancers, medullary thyroid cancer doesn't respond to radioactive iodine therapy because C cells don't absorb iodine.
Unlike other thyroid cancers, medullary thyroid cancer doesn't respond to radioactive iodine therapy because C cells don't absorb iodine. This makes complete surgical removal even more critical for cure. After surgery, patients need lifelong thyroid hormone replacement since the thyroid gland has been removed. Regular monitoring with blood tests measuring calcitonin and CEA levels helps detect any remaining or recurring cancer.
For advanced or metastatic medullary thyroid cancer, targeted therapy drugs called tyrosine kinase inhibitors can help slow cancer growth.
For advanced or metastatic medullary thyroid cancer, targeted therapy drugs called tyrosine kinase inhibitors can help slow cancer growth. The FDA has approved vandetanib and cabozantinib specifically for advanced medullary thyroid cancer. These medications work by blocking signals that cancer cells use to grow and spread. While they don't cure the cancer, they can shrink tumors and delay progression for months or years.
Traditional chemotherapy and radiation therapy have limited effectiveness against medullary thyroid cancer, though external beam radiation may be used in specific situations, such as when cancer has spread to bones or when complete surgical removal isn't possible.
Traditional chemotherapy and radiation therapy have limited effectiveness against medullary thyroid cancer, though external beam radiation may be used in specific situations, such as when cancer has spread to bones or when complete surgical removal isn't possible. Clinical trials continue to investigate new treatment approaches, including immunotherapy and newer targeted drugs. For people with hereditary forms, genetic counseling and family screening remain essential components of comprehensive care.
Living With Medullary Thyroid Cancer
Living with medullary thyroid cancer requires adapting to a new routine of regular medical monitoring and daily medication. After thyroidectomy, taking thyroid hormone replacement medication every day becomes essential for maintaining normal metabolism. Most people feel completely normal on the right dose of medication, though it may take several weeks to find the optimal amount. Regular blood tests help doctors monitor both thyroid hormone levels and tumor markers like calcitonin and CEA.
Latest Medical Developments
Latest medical developments are being researched.
Frequently Asked Questions
Update History
Apr 24, 2026v1.0.0
- Published by DiseaseDirectory